BOROSIL SCIENTIFIC LTD (BOROSCI) financials

BOROSIL SCIENTIFIC LTD (BOROSCI) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Market Cap: ₹931Cr.
Current Price: ₹105
Stock P/E: 19.6
ROE: 10.5%
ROCE: 14.2%
Book Value: ₹51.9
Dividend Yield: 0.00%
52W High / Low: ₹181/96.6

In Jun 2026, BOROSIL SCIENTIFIC LTD (BOROSCI) reported sales ₹99.90 Cr and net profit ₹6.84 Cr.

Annual TTM: sales ₹438 Cr, net profit ₹46 Cr.

Shareholding: Promoters 68.27% (Sep 2026), FIIs 0.14% (Sep 2026), DIIs 0.27% (Sep 2026), Public 31.30% (Sep 2026), No. of Shareholders 53,066% (Sep 2026).

BOROSCI quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	87.38	93.65	117.70	89.01	99.48	107.12	131.92	99.90
Expenses	73.71	81.74	96.35	80.15	87.24	89.30	100.82	88.84
Operating Profit	13.67	11.91	21.35	8.86	12.24	17.82	31.10	11.06
OPM %	15.64%	12.72%	18.14%	9.95%	12.30%	16.64%	23.57%	11.07%
Other Income	1.56	1.77	2.65	-3.55	2.37	0.72	2.12	2.80
Interest	0.18	0.18	0.18	0.18	0.09	0.09	0.06	0.10
Depreciation	4.23	4.18	4.30	4.47	4.39	4.35	4.32	4.45
Profit before tax	10.82	9.32	19.52	0.66	10.13	14.10	28.84	9.31
Tax %	28.93%	28.33%	27.41%	30.30%	25.77%	27.59%	25.35%	26.42%
Net Profit	7.69	6.68	14.17	0.46	7.52	10.21	21.54	6.84
EPS in Rs	0.87	0.75	1.59	0.05	0.85	1.15	2.42	0.77
Raw PDF	—	—	—	—	—	—	—	—

BOROSCI profit and loss (₹ Cr.)
Category	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	323	353	389	424	438
Expenses	272	301	330	353	366
Operating Profit	51	53	58	71	72
OPM %	16%	15%	15%	17%	16%
Other Income	5	4	8	1	8
Interest	1	1	1	0	0
Depreciation	12	15	17	18	18
Profit before tax	43	40	48	54	62
Tax %	29%	21%	28%	26%	—
Net Profit	30	31	35	40	46
EPS in Rs	—	3.54	3.94	4.47	5.19
Dividend Payout %	0%	0%	0%	0%	—

BOROSCI balance sheet (₹ Cr.)
Category	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.29	9	9	9
Reserves	352	374	411	453
Borrowings	11	11	6	1
Other Liabilities	69	82	74	87
Total Liabilities	432	477	499	549
Fixed Assets	150	159	155	156
CWIP	8	1	1	9
Investments	32	41	146	175
Other Assets	241	275	197	209
Total Assets	432	477	499	549

BOROSCI cash flows (₹ Cr.)
Category	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-57	32	127	50
Cash from Investing Activity	50	-20	-121	-47
Cash from Financing Activity	7	-1	-5	-4
Net Cash Flow	0	11	1	-1
Free Cash Flow	-85	20	114	25
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-97%	94%	237%	92%

BOROSCI shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	67.84%	67.81%	67.80%	67.80%	67.80%	68.08%	68.27%	68.27%
FIIs	0.27%	0.24%	0.20%	0.07%	0.07%	0.09%	0.23%	0.14%
DIIs	0.02%	0.02%	0.05%	0.10%	0.19%	0.26%	0.26%	0.27%
Public	31.88%	31.91%	31.93%	32.03%	31.93%	31.57%	31.22%	31.30%
No. of Shareholders	60,373	58,894	58,178	57,586	56,297	55,319	53,712	53,066

BOROSCI key ratios
Category	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	54	60	62
Inventory Days	325	256	227	232
Days Payable	70	102	79	98
Cash Conversion Cycle	301	208	207	196
Working Capital Days	190	181	96	92
ROCE %	—	11%	12%	14%

BOROSCIUpdated 19 Oct 2026, 20:18

Borosil Scientific Ltd

BOROSCIUpdated 19 Oct 2026, 20:18

Market Cap

₹931Cr.

Current Price

₹105

High / Low

₹181/96.6

Stock P/E

19.6

ROE10.5%

ROCE14.2%

Book Value₹51.9

Face Value₹1.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	79.71	0.3	73.44	1.04	3.37	3.64	-15.11	4.2	—
Sep 2023	84.35	0.27	71.85	1.35	3.5	10.08	23.12	7.74	—
Dec 2023	88.42	0.34	75.01	1.35	4.12	10.3	27.67	7.45	0.84
Mar 2024	102.66	0.51	83.75	1.65	4.07	15.98	24.47	12.07	1.36
Jun 2024	93.4	0.24	82.44	2.14	4.2	8.66	25.29	6.47	0.73
Sep 2024	87.38	0.18	73.71	1.56	4.23	10.82	28.93	7.69	0.87
Dec 2024	93.65	0.18	81.74	1.77	4.18	9.32	28.33	6.68	0.75
Mar 2025	117.7	0.18	96.35	2.65	4.3	19.52	27.41	14.17	1.59
Jun 2025	89.01	0.18	80.15	-3.55	4.47	0.66	30.3	0.46	0.05
Sep 2025	99.48	0.09	87.24	2.37	4.39	10.13	25.77	7.52	0.85
Dec 2025	107.12	0.09	89.3	0.72	4.35	14.1	27.59	10.21	1.15
Mar 2026	131.92	0.06	100.82	2.12	4.32	28.84	25.35	21.54	2.42
Jun 2026	99.9	0.1	88.84	2.8	4.45	9.31	26.42	6.84	0.77

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2023	323	1	272	5	12	43	29	30	—
Mar 2024	353	1	301	4	15	40	21	31	3.54
Mar 2025	389	1	330	8	17	48	28	35	3.94
Mar 2026	424	0	353	1	18	54	26	40	4.47
TTM	438	0	366	8	18	62	—	46	5.19

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	68.27%
FIIs	0.14%
DIIs	0.27%
Public	31.3%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Jun 2024	67.92%	0.38%	0.15%	31.54%
Sep 2024	67.86%	0.37%	0.01%	31.74%
Dec 2024	67.84%	0.27%	0.02%	31.88%
Mar 2025	67.81%	0.24%	0.02%	31.91%
Jun 2025	67.8%	0.2%	0.05%	31.93%
Sep 2025	67.8%	0.07%	0.1%	32.03%
Dec 2025	67.8%	0.07%	0.19%	31.93%
Mar 2026	68.08%	0.09%	0.26%	31.57%
Jun 2026	68.27%	0.23%	0.26%	31.22%
Sep 2026	68.27%	0.14%	0.27%	31.3%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2023	0.29	352	11	69	432	150	8	32	241	432
Mar 2024	9	374	11	82	477	159	1	41	275	477
Mar 2025	9	411	6	74	499	155	1	146	197	499
Mar 2026	9	453	1	87	549	156	9	175	209	549

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2023	-57	50	7	0
Mar 2024	32	-20	-1	11
Mar 2025	127	-121	-5	1
Mar 2026	50	-47	-4	-1

Key ratios

Historical financial ratios

Category	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	54	60	62
Inventory Days	325	256	227	232
Days Payable	70	102	79	98
Cash Conversion Cycle	301	208	207	196
Working Capital Days	190	181	96	92
ROCE %	—	11%	12%	14%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of BOROSIL SCIENTIFIC LTD (BOROSCI)?

The reported market capitalisation for BOROSIL SCIENTIFIC LTD (BOROSCI) is ₹931Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of BOROSCI?

The current price shown for BOROSIL SCIENTIFIC LTD (BOROSCI) on Fincrux is ₹105 with a 52-week high/low of ₹181/96.6.

What is the P/E ratio of BOROSIL SCIENTIFIC LTD (BOROSCI)?

The stock P/E for BOROSIL SCIENTIFIC LTD (BOROSCI) is 19.6 on Fincrux, with ROE at 10.5% and ROCE at 14.2%.

What were BOROSCI latest quarterly results?

For Jun 2026, BOROSIL SCIENTIFIC LTD (BOROSCI) reported sales ₹99.90 Cr and net profit ₹6.84 Cr (figures in ₹ crore unless noted).

What are BOROSCI annual sales and net profit?

For TTM, BOROSIL SCIENTIFIC LTD (BOROSCI) shows sales of ₹438 Cr and net profit of ₹46 Cr on the Fincrux profit & loss statement.

Who owns BOROSIL SCIENTIFIC LTD (BOROSCI)?

Latest shareholding for BOROSIL SCIENTIFIC LTD (BOROSCI) on Fincrux: Promoters 68.27% (Sep 2026), FIIs 0.14% (Sep 2026), DIIs 0.27% (Sep 2026), Public 31.30% (Sep 2026), No. of Shareholders 53,066% (Sep 2026).

Where can I find BOROSIL SCIENTIFIC LTD (BOROSCI) financials?

BOROSIL SCIENTIFIC LTD (BOROSCI) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show BOROSCI balance sheet and cash flow?

Yes. The BOROSIL SCIENTIFIC LTD (BOROSCI) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 20:18